Cargando…

Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study

BACKGROUND: Leber’s hereditary optic neuropathy (LHON) is a rare mitochondrial disorder, characterized by acute or subacute bilateral vision loss, frequently leading to significant chronic disability, mainly in young people. The causal LHON mutations of the mitochondrial DNA have incomplete penetran...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabenstein, Andrea, Catarino, Claudia B., Rampeltshammer, Verena, Schindler, David, Gallenmüller, Constanze, Priglinger, Claudia, Pogarell, Oliver, Rüther, Tobias, Klopstock, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953635/
https://www.ncbi.nlm.nih.gov/pubmed/33706792
http://dx.doi.org/10.1186/s13023-021-01724-5
_version_ 1783663954594103296
author Rabenstein, Andrea
Catarino, Claudia B.
Rampeltshammer, Verena
Schindler, David
Gallenmüller, Constanze
Priglinger, Claudia
Pogarell, Oliver
Rüther, Tobias
Klopstock, Thomas
author_facet Rabenstein, Andrea
Catarino, Claudia B.
Rampeltshammer, Verena
Schindler, David
Gallenmüller, Constanze
Priglinger, Claudia
Pogarell, Oliver
Rüther, Tobias
Klopstock, Thomas
author_sort Rabenstein, Andrea
collection PubMed
description BACKGROUND: Leber’s hereditary optic neuropathy (LHON) is a rare mitochondrial disorder, characterized by acute or subacute bilateral vision loss, frequently leading to significant chronic disability, mainly in young people. The causal LHON mutations of the mitochondrial DNA have incomplete penetrance, with the highest risk of disease manifestation for male mutation carriers in the second and third decades of life. Here we evaluated smoking, alcohol drinking habits, health-related quality of life (QOL) and psychiatric comorbidities in a cohort of LHON patients and asymptomatic mutation carriers from a tertiary referral centre. METHODS: Cross-sectional analysis of the ongoing Munich LHON prospective cohort study. Participants included all LHON patients and asymptomatic LHON mutation carriers older than 16 years at baseline, who were recruited between February 2014 and June 2015 and consented to participate. General, neurological and ophthalmological investigations were performed, including validated questionnaires on smoking, alcohol drinking habits, depressive symptoms and health-related QOL. RESULTS: Seventy-one participants were included, 34 LHON patients (82% male) and 37 asymptomatic mutation carriers (19% male). Median age at baseline was 36 years (range 18–75 years). For LHON patients, median age at visual loss onset was 27 years (9 to 72 years). Smoking is more frequent in LHON patients than asymptomatic LHON mutation carriers, and significantly more frequent in both groups than in the general population. Sixty percent of LHON patients, who smoked at disease onset, stopped or significantly reduced smoking after visual loss onset, yet 40% of LHON patients continued to smoke at study baseline. Excessive alcohol consumption is more frequent in male LHON patients than in LHON asymptomatic and more frequent than in the male general population. Further, female asymptomatic LHON mutation carriers are at risk for depression and worse mental QOL scores. CONCLUSIONS: Given the high prevalence of smoking and excessive drinking in LHON mutation carriers, implementing effective measures to reduce these risk factors may have a significant impact in reducing LHON disease conversion risk. The underrecognized prevalence of mental health issues in this population of LHON mutation carriers highlights the need for awareness and more timely diagnosis, which may lead to improved outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01724-5.
format Online
Article
Text
id pubmed-7953635
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79536352021-03-12 Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study Rabenstein, Andrea Catarino, Claudia B. Rampeltshammer, Verena Schindler, David Gallenmüller, Constanze Priglinger, Claudia Pogarell, Oliver Rüther, Tobias Klopstock, Thomas Orphanet J Rare Dis Research BACKGROUND: Leber’s hereditary optic neuropathy (LHON) is a rare mitochondrial disorder, characterized by acute or subacute bilateral vision loss, frequently leading to significant chronic disability, mainly in young people. The causal LHON mutations of the mitochondrial DNA have incomplete penetrance, with the highest risk of disease manifestation for male mutation carriers in the second and third decades of life. Here we evaluated smoking, alcohol drinking habits, health-related quality of life (QOL) and psychiatric comorbidities in a cohort of LHON patients and asymptomatic mutation carriers from a tertiary referral centre. METHODS: Cross-sectional analysis of the ongoing Munich LHON prospective cohort study. Participants included all LHON patients and asymptomatic LHON mutation carriers older than 16 years at baseline, who were recruited between February 2014 and June 2015 and consented to participate. General, neurological and ophthalmological investigations were performed, including validated questionnaires on smoking, alcohol drinking habits, depressive symptoms and health-related QOL. RESULTS: Seventy-one participants were included, 34 LHON patients (82% male) and 37 asymptomatic mutation carriers (19% male). Median age at baseline was 36 years (range 18–75 years). For LHON patients, median age at visual loss onset was 27 years (9 to 72 years). Smoking is more frequent in LHON patients than asymptomatic LHON mutation carriers, and significantly more frequent in both groups than in the general population. Sixty percent of LHON patients, who smoked at disease onset, stopped or significantly reduced smoking after visual loss onset, yet 40% of LHON patients continued to smoke at study baseline. Excessive alcohol consumption is more frequent in male LHON patients than in LHON asymptomatic and more frequent than in the male general population. Further, female asymptomatic LHON mutation carriers are at risk for depression and worse mental QOL scores. CONCLUSIONS: Given the high prevalence of smoking and excessive drinking in LHON mutation carriers, implementing effective measures to reduce these risk factors may have a significant impact in reducing LHON disease conversion risk. The underrecognized prevalence of mental health issues in this population of LHON mutation carriers highlights the need for awareness and more timely diagnosis, which may lead to improved outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01724-5. BioMed Central 2021-03-11 /pmc/articles/PMC7953635/ /pubmed/33706792 http://dx.doi.org/10.1186/s13023-021-01724-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rabenstein, Andrea
Catarino, Claudia B.
Rampeltshammer, Verena
Schindler, David
Gallenmüller, Constanze
Priglinger, Claudia
Pogarell, Oliver
Rüther, Tobias
Klopstock, Thomas
Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study
title Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study
title_full Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study
title_fullStr Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study
title_full_unstemmed Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study
title_short Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study
title_sort smoking and alcohol, health-related quality of life and psychiatric comorbidities in leber’s hereditary optic neuropathy mutation carriers: a prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953635/
https://www.ncbi.nlm.nih.gov/pubmed/33706792
http://dx.doi.org/10.1186/s13023-021-01724-5
work_keys_str_mv AT rabensteinandrea smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy
AT catarinoclaudiab smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy
AT rampeltshammerverena smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy
AT schindlerdavid smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy
AT gallenmullerconstanze smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy
AT priglingerclaudia smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy
AT pogarelloliver smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy
AT ruthertobias smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy
AT klopstockthomas smokingandalcoholhealthrelatedqualityoflifeandpsychiatriccomorbiditiesinlebershereditaryopticneuropathymutationcarriersaprospectivecohortstudy